REDWOOD CITY, Calif., Feb. 26, 2024 (Globe Newswire) — Codexis, Inc. (NASDAQ: CDXS), a leading enzyme engineering company, today announced that the company will attend TD Cowen 44.th The annual healthcare conference will be held March 4-6, 2024 in Boston, Massachusetts.
Management will participate in a fireside chat on Monday, March 4, 2024 at 2:50 PM ET. A live webcast of the event is available here and in the Investor Relations section of our website at http://ir.codexis.com. Replays will be archived for 90 days after the event.
About Codesis
Codexis is a leading enzyme engineering company that leverages its proprietary CodeEvolver® technology platform to discover, develop, and enhance novel high-performance enzymes and other classes of proteins. Codexis enzymes solve real-world challenges related to small molecule drug manufacturing and nucleic acid synthesis. The Company is currently developing its proprietary ECO Synthesis™ manufacturing platform, which will enable large-scale manufacturing of RNAi therapeutics via the enzymatic route. Codexis' proprietary enzymes can drive improvements such as higher yields, reduced energy use and waste generation, increased manufacturing efficiency, and increased sensitivity for genomic and diagnostic applications. For more information, please visit https://www.codexis.com.
For more information
Investor contact information
Carrie McKim
(336) 608-9706
ir@codexis.com
media contact
Lauren Musto
(650) 421-8205
media@codexis.com
